These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 2201275)

  • 41. [Effects of fibrinogen, fibrin and their degradation products on the behaviour of vascular smooth muscle cells].
    Naito M
    Nihon Ronen Igakkai Zasshi; 2000 Jun; 37(6):458-63. PubMed ID: 10998926
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fibrinogen, fibrin turnover, endothelial products and vascular surgery.
    Woodburn KR; Lowe GD
    Br J Surg; 1997 Aug; 84(8):1059-64. PubMed ID: 9278641
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fibrinogen, fibrin and the arterial wall.
    Smith EB
    Eur Heart J; 1995 Mar; 16 Suppl A():11-4; discussion 14-5. PubMed ID: 7796823
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Factors influencing the accumulation in fibrous plaques of lipid derived from low density lipoprotein. I. Relation between fibrin and immobilization of apo B-containing lipoprotein.
    Smith EB; Keen GA; Grant A
    Atherosclerosis; 1990 Oct; 84(2-3):165-71. PubMed ID: 2149267
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Localization of apolipoprotein E in normal and atherosclerotic human aorta.
    Babaev VR; Dergunov AD; Chenchik AA; Tararak EM; Yanushevskaya EV; Trakht IN; Sorg C; Smirnov VN
    Atherosclerosis; 1990 Dec; 85(2-3):239-47. PubMed ID: 2102087
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Atherosclerosis: coagulation and fibrinolysis.
    Sueishi K; Ichikawa K; Kato K; Nakagawa K; Chen YX
    Semin Thromb Hemost; 1998; 24(3):255-60. PubMed ID: 9701457
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fibrin deposition and fibrin degradation products in atherosclerotic plaques.
    Smith EB
    Thromb Res; 1994 Aug; 75(3):329-35. PubMed ID: 7992244
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Plasma fibrinogen as a cardiovascular risk factor].
    Naito M; Hayashi T; Iguchi A
    Nihon Ronen Igakkai Zasshi; 1994 Mar; 31(3):213-8. PubMed ID: 8207872
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fibrin and its derivatives in the normal and diseased vessel wall.
    Bini A; Kudryk BJ
    Ann N Y Acad Sci; 1992 Dec; 667():112-26. PubMed ID: 1309030
    [No Abstract]   [Full Text] [Related]  

  • 50. [Interaction of low density lipoproteins with fibrinogen and basic proteins].
    Skrzydlewski Z; Wiśniewski L; Głowiński S; Worowski K
    Patol Pol; 1979; 30(3):415-20. PubMed ID: 232260
    [No Abstract]   [Full Text] [Related]  

  • 51. [Fibrin deposits and fibrinolysis in pre and early stages of arteriosclerosis].
    Kopeć M
    Z Gesamte Inn Med; 1978 Sep; 33(17):613-5. PubMed ID: 151992
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Repair in arterial tissue. Demonstration of fibrinogen/fibrin in the normal and healing rabbit thoracic aorta by the indirect immunoperoxidase technique.
    Chemnitz J; Christensen BC
    Virchows Arch A Pathol Anat Histopathol; 1984; 403(2):163-71. PubMed ID: 6426160
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Atherosclerotic plaque growth: presence of stimulatory fibrin degradation products.
    Thompson WD; Smith EB; Stirk CM; Kochhar A
    Blood Coagul Fibrinolysis; 1990 Oct; 1(4-5):489-93. PubMed ID: 1723306
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunoelectrophoretic and immunohistochemical characterizations of fibrinogen derivatives in atherosclerotic aortic intimas and vascular prosthesis pseudo-intimas.
    Valenzuela R; Shainoff JR; DiBello PM; Urbanic DA; Anderson JM; Matsueda GR; Kudryk BJ
    Am J Pathol; 1992 Oct; 141(4):861-80. PubMed ID: 1415480
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Distribution patterns of apolipoproteins A1, A2, and B in the wall of atherosclerotic vessels.
    Vollmer E; Brust J; Roessner A; Bosse A; Burwikel F; Kaesberg B; Harrach B; Robenek H; Böcker W
    Virchows Arch A Pathol Anat Histopathol; 1991; 419(2):79-88. PubMed ID: 1908160
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Plasma protein insudation as an index of early coronary atherogenesis.
    Zhang Y; Cliff WJ; Schoefl GI; Higgins G
    Am J Pathol; 1993 Aug; 143(2):496-506. PubMed ID: 8342598
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fibronectin in multiple sclerosis lesions.
    Sobel RA; Mitchell ME
    Am J Pathol; 1989 Jul; 135(1):161-8. PubMed ID: 2528301
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [A method of determining the anti-, de- and fibrin-polymerization activity of the blood plasma].
    Pastorova VE; Liapina LA; Kudriashov BA; Tabakina TE
    Lab Delo; 1990; (7):53-7. PubMed ID: 1699071
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The immunopathology of acute experimental allergic encephalomyelitis. V. A light microscopic and ultrastructural immunohistochemical analysis of fibronectin and fibrinogen.
    Sobel RA; Schneeberger EE; Colvin RB
    Am J Pathol; 1988 Jun; 131(3):547-58. PubMed ID: 2968050
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [The clinical manifestations and the plasma levels of fibronectin and fibrin-fibrinogen degradation products in different morphological forms of chronic hepatitis].
    Malaia LT; Iabluchanskiĭ NI; Panchuk SN; Babak OIa
    Ter Arkh; 1991; 63(11):44-6. PubMed ID: 1810062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.